Advancing RSV Prevention: A New Path Forward
El primer glosario de evidencia del mundo cuantifica el impacto que tienen las enfermedades reumáticas inflamatorias
La Alianza Global para el Acceso de Pacientes (GAfPA) ha presentado hoy el Glosario sobre el valor de lograr la remisión en enfermedades reumáticas inflamatorias, donde se ofrece por primera vez una imagen completa del impacto clínico, social y económico que tienen estas enfermedades.
Il primo glossario di evidenze al mondo quantifica l’impatto delle condizioni reumatiche infiammatorie
La Global Alliance for Patient Access (GAfPA) ha lanciato oggi il Glossario Value of Achieving Remission in Inflammatory Rheumatic Conditions, fornendo per la prima volta un quadro completo dell’impatto clinico, sociale ed economico delle condizioni.
Le premier registre de données probantes au monde quantifie l’impact des rhumatismes inflammatoires
Global Alliance for Patient Access (GAfPA) lance aujourd’hui le Value of Achieving Remission in Inflammatory Rheumatic Conditions Glossary (Registre de la valeur de la rémission dans les rhumatismes inflammatoires), qui brosse un tableau complet de l’impact clinique, social et économique de ces affections et ce, pour la toute première fois.
Das Weltweit erste Evidenzglossar Quantifiziert die Auswirkungen von Entzündlichen Rheumatischen Erkrankungen
Global Alliance for Patient Access: Das weltweit erste Evidenzglossar quantifiziert die Auswirkungen von entzündlichen rheumatischen Erkrankungen
Make the Change for Kidney Health
Chronic kidney disease – CKD – poses a growing burden across the globe. CKD affects more than 10% of the world’s population, or approximately 850 million people, and is projected to be the world’s fifth leading cause of death by 2040. Yet it’s not considered a priority among non-communicable diseases.
Kidney Health for All
Chronic kidney disease affects more than 10% of the world’s population, around 850 million people. World Kidney Day aims to bring that number down – by raising awareness, advancing screening and improving access to treatment.
Illuminating Advocacy: Rare Disease Day
February 29 unites more than 300 million people worldwide who share a common challenge: living with a rare disease.
Protecting Patient Access to Clinical Trials in Europe
An all-encompassing revision of pharmaceutical laws from the European Commission aims to make medications more available, accessible and affordable. But these revisions could have unintended consequences for patients’ access to clinical trials and new treatments.
New Global Patient Alliance Is Raising Profile of Chronic Kidney Disease
A new global coalition, the Global Patient Alliance for Kidney Health, launched last week. With 17 member organizations spanning five continents, the Alliance hopes to improve screening access and early treatment for a serious but often neglected public health challenge: chronic kidney disease, or CKD.
